乳糖酶缺乏基础研究进展.pdf.pdf

文档介绍：1842·[12][13][14][15][16]医学综述8年6月第l4卷第12期MedicalRecapitulate。[J].Ophthalmology,2oo8,l15(2):398-,Cheng,:quantitativereviewoftheevidence[J].Ophthalmologica,2oo8,222(1):27-,TanH,SaeedP,:Isitsafe?Along—termfollow一pstudy[J].Ophthalmology,2Oo4,l11(8):1557—,ZhangL,UddinJ,—tostatinreceptorsubtypesinGravesophthalmopathyorbits:[J].AmJPhysiolEndocrinolMetab,2oo7,293(6):,GarrityJA,BradleyEA,,double—blind,placebo—-mentofGravesophthalmopathy【J】.,91(12):4817-,VaidyaB,MillerM,—blind,placebo—controUedtrialofoctreotidelong—actingrepeatable(LAR)inthy—mid-associatedophthalmo—pathy『J】.JClinEndocrinolMetab,2oo4,B9(12):5910-,OkadaY,,2006,28(2):185—191.[17][18][19][2O][21][22][J].Eye,2OO6,20(10):1171—,[J].Ex_pertOpinBiolTher,2oo7,7(7):1061—,NielsenCH,BonnemaSJ,